Morgan Stanley Maia Biotechnology, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 5,095 shares of MAIA stock, worth $11,514. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,095

Previous 5,095 -0.0%

Holding current value

$11,514

Previous $17,000 17.65%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$1.96 - $5.1 $9,800 - $25,500	-5,000 Reduced 49.53%	5,095 $17,000
Q2 2024 Aug 14, 2024	SELL	$1.96 - $5.1 $9,800 - $25,500	-5,000 Reduced 49.53%	5,095 $17,000
Q1 2024 Oct 17, 2024	BUY	$1.1 - $2.55 $5,500 - $12,750	5,000 Added 98.14%	10,095 $22,000
Q1 2024 Aug 16, 2024	BUY	$1.1 - $2.55 $5,500 - $12,750	5,000 Added 98.14%	10,095 $22,000
Q1 2024 May 15, 2024	BUY	$1.1 - $2.55 $5,500 - $12,750	5,000 Added 98.14%	10,095 $22,000
Q3 2023 Nov 15, 2023	BUY	$1.42 - $2.41 $7,234 - $12,278	5,095 New	5,095 $11,000

Others Institutions Holding MAIA

# of Institutions

Shares Held

1.47M

Call Options Held

Put Options Held

View Full List

About MAIA Biotechnology, Inc.

Ticker MAIA
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,935,900
Market Cap $24.7M
Description
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...

More about MAIA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account